This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HARRY F. DOWLING, M.D.

AMA Arch Intern Med. 1957;100(4):529-534.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Drugs are discovered, manufactured, and tested by scientific methods. On the other hand they are produced and marketed through a blend of personal and social motives; they are prescribed by doctors with varying knowledges and skills, and they are taken by patients who have different degrees of information, interest, and precision. Drugs are brewed in the cup of science; they are drunk through a patient's lips, and "there's many a slip twixt the cup and the lip."

Scientific attention is usually turned toward the discovery of drugs; in the present paper I shall consider the path from their development to their use. As an example, let us take chlortetracycline, one of the first antibiotics to be produced by a pharmaceutical company. After screening hundreds of specimens of soil, Duggar isolated Streptomyces aureofaciens, in the fall of 1945. Its in vitro antibacterial activity was demonstrated later in the same year.

Preparation . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Research and Educational Hospitals and the Department of Medicine, University of Illinois.

Footnotes
Submitted for publication May 17, 1957.

This paper is being published simultaneously in The Journal of the American Medical Association.

Chairman's address, read before the Section on Experimental Medicine and Therapeutics at the 106th Annual Meeting of the American Medical Association, New York, June 4, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?